Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
Lipidio Pharmaceuticals focuses on advancing a molecule to treat diseases associated with excess body fat.
Gate Neurosciences is a healthcare company that offers neuroscience-related medical services.
Mebias Discovery holds a game-changing platform to discover next generation.
Tridek-One is a biopharmaceutical company aiming to develop immunomodulatory compounds targeting the CD31 pathway.
Regenacy Pharmaceuticals Provides Healthcare Services.
Stimdia Medical is a developer of a lung pacing device intended to facilitate weaning patients from mechanical ventilation.
Tetris Therapeutics is a platform-based biotechnology company
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.
Pathware is creating hardware and software to simplify digital pathology workflows.
Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.
Improving medical decision making through an EHR-integrated B2B SaaS platform for hospitals and front-line clinicians.
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.
Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.
Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines.
Developer of a miniature biosensing device intended to use a small blood volume to derive data on multiple biomarkers present in the sample.
DeepSight Technology's vision is to reinvent diagnostic imaging.
IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
NeuralGalaxy is a brain science company which is devoted to solve brain disorders.
Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider.
AccuPulse is developing novel pulsed electric field ablation (PFA) generator and catheters.
Yili Pharmaceutical is a pharmaceutical R&D company.
Lingchu is an embodied intelligence startup company that specializes in robot skill set training using reinforcement learning algorithms
BioVenture has invested in 279 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Biotechnology, Health Care, Medical, Biopharma, Life Science. The firm invests across 29 different industry categories.
Among tracked funding rounds, Lingchu Intelligence received $290.4M in a Seed round. BioVenture's total known invested capital is $2.1B.
BioVenture's average investment size is $23.9M across its portfolio of 279 companies.
Recent BioVenture portfolio additions include Apexigen, Lipidio Pharmaceuticals, Gate Neurosciences, Mebias Discovery, Tridek-One. These companies were founded in 2020 or later.